Clinical Trial Update: Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Memorial Sloan Kettering tested sequential chemotherapy and lenalidomide followed by rituximab and lenalidomide maintenance in unt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Mantle Cell Lymphoma, Untreated | Phase 2 | Status: COMPLETED | Results posted: 2024-08-30